Literature DB >> 9574833

Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain.

J Turchan1, W Lasoń, B Budziszewska, B Przewłocka.   

Abstract

Effects of single (20 mg/kg i.p.) and repeated morphine administration (increasing doses: from 10 to 50 mg/kg i.p. twice daily for 7 days) on the proenkephalin (PENK), prodynorphin (PDYN) and dopamine D2 receptor (D2) mRNA levels in the nucleus accumbens and striatum of the mouse were investigated. As shown by an in situ hybridization, a single dose of morphine had no significant effect on the PDYN, PENK and D2 mRNA levels in the nucleus accumbens and striatum. Repeated treatment with morphine increased the PDYN mRNA level in both those structures after 2 and 72 h. In contrast to PDYN, the PENK mRNA level was reduced in the nucleus accumbens and remained unchanged in the striatum following repeated morphine administration. Repeated morphine had no effect on the D2 mRNA level in the nucleus accumbens and striatum after 2 h, and decreased it in the nucleus accumbens after 72 h only. The above results indicate that repeated morphine leads to long-lasting upregulation of the PDYN gene expression in the mouse nucleus accumbens and striatum; on the other hand, the PENK and D2 mRNA gene expressions are either inhibited or remain unchanged, significant changes being observed in the nucleus accumbens only.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9574833     DOI: 10.1016/s0143-4179(97)90015-9

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  22 in total

Review 1.  Recent advances in the biology of addiction.

Authors:  S E Hemby
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

2.  Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway.

Authors:  Benjamin N Greenwood; Teresa E Foley; Tony V Le; Paul V Strong; Alice B Loughridge; Heidi E W Day; Monika Fleshner
Journal:  Behav Brain Res       Date:  2010-11-09       Impact factor: 3.332

Review 3.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 4.  Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

Authors:  Mary Jeanne Kreek; Orna Levran; Brian Reed; Stefan D Schlussman; Yan Zhou; Eduardo R Butelman
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

5.  The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal.

Authors:  Angelo Contarino; Francesco Papaleo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

6.  Neurobiology of dysregulated motivational systems in drug addiction.

Authors:  Scott Edwards; George F Koob
Journal:  Future Neurol       Date:  2010-05-01

Review 7.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

8.  In vivo regulation of the μ opioid receptor: role of the endogenous opioid agents.

Authors:  Veronica Gonzalez-Nunez; Ada Jimenez González; Katherine Barreto-Valer; Raquel E Rodríguez
Journal:  Mol Med       Date:  2013-03-05       Impact factor: 6.354

Review 9.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

Review 10.  Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.

Authors:  T S Shippenberg; A LeFevour; V I Chefer
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.